July 9, 2007- Medtronic Inc. announced the European introduction of the Reveal DX, a new insertable cardiac monitor that offers diagnostic and monitoring information related to syncope (fainting) in patients.
The device recently received the CE (Conformite Europeenne) Mark, and the first implant of Reveal DX took place at Ospedali del Tigullio in Lavagna, Italy, by Professor Michele Brignole, M.D. Placed just under the skin of the chest area using local anesthesia during a simple outpatient procedure, the monitor records important data before, during and after a syncopal event. This data enables the physician to diagnose the patient and determine the right
treatment based on long-term cardiac rhythm trend data. The Reveal DX insertable cardiac monitor is not currently available for sale in the United States.
With the information obtained from the Reveal DX, the physician can reportedly understand if the cause of syncope is cardiac related, designed to help to appropriately manage the patient’s arrhythmia.
For more information: www.medtronic.com
October 29, 2026 
